Pharmeca.cz

A decision of the Ministry of Health of the Czech Republic regarding the appeal of the appelant s Teva Pharmaceuticals CR, s.r.o. and Merck Europe B.V., against the decision of the State Institute for Drug Control from 24. 2. 2022, under the no.: SUKLS81849/2014:

• the operative parts 7 and 8 of the decision under appeal is reversed and the issue is referred back to the State Institute for Drug Control for reappraisal
• The rest of the decision under appeal is upheld

More information: MZCR.cz.